{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T16:42:03Z","timestamp":1772383323738,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Schistosomiasis is a serious but neglected parasitic disease in humans that may lead to liver fibrosis and death. Activated hepatic stellate cells (HSCs) are the principal effectors that promote the accumulation of extracellular matrix (ECM) proteins during hepatic fibrosis. Aberrant microRNA-29 expression is involved in the development of fibrotic diseases. However, less is known about the role of miR-29 in <jats:italic>Schistosoma japonicum<\/jats:italic> (<jats:italic>S. japonicum<\/jats:italic>)-induced hepatic fibrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The levels of microRNA-29a-3p (miR-29a-3p) and Roundabout homolog 1 (Robo1) were examined in liver tissues during <jats:italic>S. japonicum<\/jats:italic> infection. The possible involvement of the miR-29a-3p-Robo1 signaling pathway was determined. We used MIR29A conditional knock-in mice and mice injected with an miR-29a-3p agomir to investigate the role of miR-29a-3p in schistosomiasis-induced hepatic fibrosis. The functional contributions of miR-29a-3p-Robo1 signaling in liver fibrosis and HSC activation were investigated using primary mouse HSCs and the human HSC cell line LX-2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>MiR-29a-3p was downregulated in humans and mice with schistosome-induced fibrosis, and Robo1 was upregulated in liver tissues. The miR-29a-3p targeted Robo1 and negatively regulated its expression. Additionally, the expression level of miR-29a-3p in schistosomiasis patients was highly correlated with the portal vein and spleen thickness diameter, which represent the severity of fibrosis. Furthermore, we demonstrated that efficient and sustained elevation of miR-29a-3p reversed schistosome-induced hepatic fibrosis. Notably, we showed that miR-29a-3p targeted Robo1 in HSCs to prevent the activation of HSCs during infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results provide experimental and clinical evidence that the miR-29a-3p-Robo1 signaling pathway in HSCs plays an important role in the development of hepatic fibrosis. Therefore, our study highlights the potential of miR-29a-3p as a therapeutic intervention for schistosomiasis and other fibrotic diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-023-05791-4","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:13:02Z","timestamp":1686078782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells"],"prefix":"10.1186","volume":"16","author":[{"given":"Hongyan","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuaiwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanyue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaquan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"5791_CR1","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet"},{"key":"5791_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/sj.icb.7100014","volume":"85","author":"MS Wilson","year":"2007","unstructured":"Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol. 2007;85:148\u201354.","journal-title":"Immunol Cell Biol"},{"key":"5791_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/pim.12087","volume":"36","author":"DG Colley","year":"2014","unstructured":"Colley DG, Secor WE. Immunology of human schistosomiasis. Parasite Immunol. 2014;36:347\u201357.","journal-title":"Parasite Immunol"},{"key":"5791_CR4","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.3389\/fimmu.2018.02781","volume":"9","author":"SD Kamdem","year":"2018","unstructured":"Kamdem SD, Moyou-Somo R, Brombacher F, Nono JK. Host regulators of liver fibrosis during human schistosomiasis. Front Immunol. 2018;9:2781.","journal-title":"Front Immunol"},{"key":"5791_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1152\/physrev.00013.2007","volume":"88","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev. 2008;88:125\u201372.","journal-title":"Physiol Rev"},{"key":"5791_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijpara.2006.04.015","volume":"36","author":"PB Bartley","year":"2006","unstructured":"Bartley PB, Ramm GA, Jones MK, Ruddell RG, Li Y, McManus DP. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol. 2006;36:993\u20131001.","journal-title":"Int J Parasitol"},{"key":"5791_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195\u2013206.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"5791_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ncpgasthep0055","volume":"1","author":"SL Friedman","year":"2004","unstructured":"Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol. 2004;1:98\u2013105.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"5791_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"5791_CR10","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655\u201369.","journal-title":"Gastroenterology"},{"key":"5791_CR11","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S0140-6736(06)69440-3","volume":"368","author":"B Gryseels","year":"2006","unstructured":"Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368:1106\u201318.","journal-title":"Lancet"},{"key":"5791_CR12","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1002\/hep.27671","volume":"61","author":"X He","year":"2015","unstructured":"He X, Xie J, Zhang D, Su Q, Sai X, Bai R, et al. Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways. Hepatology. 2015;61:2008\u201317.","journal-title":"Hepatology"},{"key":"5791_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1756-3305-7-148","volume":"7","author":"D Zhu","year":"2014","unstructured":"Zhu D, He X, Duan Y, Chen J, Wang J, Sun X, et al. Expression of microRNA-454 in TGF-beta1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum. Parasit Vectors. 2014;7:148.","journal-title":"Parasit Vectors"},{"key":"5791_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.pt.2018.02.005","volume":"34","author":"JP Carson","year":"2018","unstructured":"Carson JP, Ramm GA, Robinson MW, McManus DP, Gobert GN. Schistosome-induced fibrotic disease: the role of hepatic stellate cells. Trends Parasitol. 2018;34:524\u201340.","journal-title":"Trends Parasitol"},{"key":"5791_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","volume":"10","author":"AM Gressner","year":"2006","unstructured":"Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med. 2006;10:76\u201399.","journal-title":"J Cell Mol Med"},{"key":"5791_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"5791_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333.","journal-title":"Cell"},{"key":"5791_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2004.12.031","volume":"120","author":"E Berezikov","year":"2005","unstructured":"Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120:21\u20134.","journal-title":"Cell"},{"key":"5791_CR19","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1111\/j.1742-4658.2010.07632.x","volume":"277","author":"X Jiang","year":"2010","unstructured":"Jiang X, Tsitsiou E, Herrick SE, Lindsay MA. MicroRNAs and the regulation of fibrosis. FEBS J. 2010;277:2015\u201321.","journal-title":"FEBS J"},{"key":"5791_CR20","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1084\/jem.20100035","volume":"207","author":"G Liu","year":"2010","unstructured":"Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207:1589\u201397.","journal-title":"J Exp Med"},{"key":"5791_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003205","volume":"4","author":"BN Chau","year":"2012","unstructured":"Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med. 2012;4:121ra18.","journal-title":"Sci Transl Med."},{"key":"5791_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53:209\u201318.","journal-title":"Hepatology"},{"key":"5791_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006957","volume":"14","author":"X He","year":"2018","unstructured":"He X, Xie J, Wang Y, Fan X, Su Q, Sun Y, et al. Down-regulation of microRNA-203-3p initiates type 2 pathology during schistosome infection via elevation of interleukin-33. PLoS Pathog. 2018;14:e1006957.","journal-title":"PLoS Pathog"},{"key":"5791_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jhep.2019.10.029","volume":"72","author":"X He","year":"2020","unstructured":"He X, Wang Y, Fan X, Lei N, Tian Y, Zhang D, et al. A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III. J Hepatol. 2020;72:519\u201327.","journal-title":"J Hepatol"},{"key":"5791_CR25","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1002\/jcp.26469","volume":"233","author":"Y Huang","year":"2018","unstructured":"Huang Y, Fan X, Tao R, Song Q, Wang L, Zhang H, et al. Effect of miR-182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K\/AKT signaling pathway. J Cell Physiol. 2018;233:6693\u2013704.","journal-title":"J Cell Physiol"},{"key":"5791_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3390\/ijms18010192","volume":"18","author":"YL Yang","year":"2017","unstructured":"Yang YL, Wang FS, Li SC, Tiao MM, Huang YH. MicroRNA-29a alleviates bile duct ligation exacerbation of hepatic fibrosis in mice through epigenetic control of methyltransferases. Int J Mol Sci. 2017;18:192.","journal-title":"Int J Mol Sci"},{"key":"5791_CR27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biomaterials.2015.10.047","volume":"76","author":"V Kumar","year":"2016","unstructured":"Kumar V, Mondal G, Dutta R, Mahato RI. Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis. Biomaterials. 2016;76:144\u201356.","journal-title":"Biomaterials"},{"key":"5791_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ydbio.2007.10.052","volume":"313","author":"W Andrews","year":"2008","unstructured":"Andrews W, Barber M, Hernadez-Miranda LR, Xian J, Rakic S, Sundaresan V, et al. The role of Slit-Robo signaling in the generation, migration and morphological differentiation of cortical interneurons. Dev Biol. 2008;313:648\u201358.","journal-title":"Dev Biol"},{"key":"5791_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MNH.0b013e32836235f4","volume":"22","author":"DA Yuen","year":"2013","unstructured":"Yuen DA, Robinson LA. Slit2-Robo signaling: a novel regulator of vascular injury. Curr Opin Nephrol Hypertens. 2013;22:445\u201351.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"5791_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000351023","volume":"35","author":"ME Cornide-Petronio","year":"2013","unstructured":"Cornide-Petronio ME, Barreiro-Iglesias A. Role of Slit and Robo proteins in the development of dopaminergic neurons. Dev Neurosci. 2013;35:285\u201392.","journal-title":"Dev Neurosci"},{"key":"5791_CR31","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1530\/REP-10-0017","volume":"139","author":"RE Dickinson","year":"2010","unstructured":"Dickinson RE, Duncan WC. The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction. 2010;139:697\u2013704.","journal-title":"Reproduction"},{"key":"5791_CR32","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1186\/s12885-015-1984-4","volume":"15","author":"T Huang","year":"2015","unstructured":"Huang T, Kang W, Cheng AS, Yu J, To KF. The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers. BMC Cancer. 2015;15:950.","journal-title":"BMC Cancer"},{"key":"5791_CR33","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-12-386503-8.00005-3","volume":"114","author":"MS Ballard","year":"2012","unstructured":"Ballard MS, Hinck L. A roundabout way to cancer. Adv Cancer Res. 2012;114:187\u2013235.","journal-title":"Adv Cancer Res"},{"key":"5791_CR34","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1681\/ASN.2015040356","volume":"27","author":"DA Yuen","year":"2016","unstructured":"Yuen DA, Huang YW, Liu GY, Patel S, Fang F, Zhou J, et al. Recombinant N-terminal Slit2 Inhibits TGF-beta-induced fibroblast activation and renal fibrosis. J Am Soc Nephrol. 2016;27:2609\u201315.","journal-title":"J Am Soc Nephrol"},{"key":"5791_CR35","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jhep.2015.07.033","volume":"63","author":"J Chang","year":"2015","unstructured":"Chang J, Lan T, Li C, Ji X, Zheng L, Gou H, et al. Activation of Slit2-Robo1 signaling promotes liver fibrosis. J Hepatol. 2015;63:1413\u201320.","journal-title":"J Hepatol"},{"key":"5791_CR36","doi-asserted-by":"publisher","first-page":"175883592093789","DOI":"10.1177\/1758835920937890","volume":"12","author":"Q Song","year":"2020","unstructured":"Song Q, Zhang H, He J, Kong H, Tao R, Huang Y, et al. Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K\/AKT\/mTOR signaling pathway. Ther Adv Med Oncol. 2020;12:1758835920937890.","journal-title":"Ther Adv Med Oncol"},{"key":"5791_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13071-018-3223-8","volume":"12","author":"WJ Zhang","year":"2019","unstructured":"Zhang WJ, Fang ZM, Liu WQ. NLRP3 inflammasome activation from Kupffer cells is involved in liver fibrosis of Schistosoma japonicum-infected mice via NF-kappaB. Parasit Vectors. 2019;12:29.","journal-title":"Parasit Vectors"},{"key":"5791_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.986943","volume":"9","author":"WJ Lv","year":"2022","unstructured":"Lv WJ, Huang JY, Li SP, Gong XP, Sun JB, Mao W, et al. Portulaca oleracea L. extracts alleviate 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice. Front Nutr. 2022;9:986943.","journal-title":"Front Nutr"},{"key":"5791_CR39","doi-asserted-by":"publisher","first-page":"1050093","DOI":"10.3389\/fphar.2022.1050093","volume":"13","author":"B Li","year":"2022","unstructured":"Li B, Zhou J, Luo Y, Tao K, Zhang L, Zhao Y, et al. Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p\/Col1a1 axis. Front Pharmacol. 2022;13:1050093.","journal-title":"Front Pharmacol"},{"key":"5791_CR40","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"5791_CR41","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/dna.2006.0538","volume":"26","author":"G Wheeler","year":"2007","unstructured":"Wheeler G, Valoczi A, Havelda Z, Dalmay T. In situ detection of animal and plant microRNAs. DNA Cell Biol. 2007;26:251\u20135.","journal-title":"DNA Cell Biol"},{"key":"5791_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tips.2014.01.003","volume":"35","author":"N Pottier","year":"2014","unstructured":"Pottier N, Cauffiez C, Perrais M, Barbry P, Mari B. FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. Trends Pharmacol Sci. 2014;35:119\u201326.","journal-title":"Trends Pharmacol Sci"},{"key":"5791_CR43","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E van Rooij","year":"2008","unstructured":"van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A. 2008;105:13027\u201332.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5791_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1158\/0008-5472.CAN-06-2559","volume":"67","author":"E Labb\u00e9","year":"2007","unstructured":"Labb\u00e9 E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, et al. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Can Res. 2007;67:75\u201384.","journal-title":"Can Res"},{"key":"5791_CR45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1590\/S0074-02762010000400018","volume":"105","author":"CN Morais","year":"2010","unstructured":"Morais CN, Carvalho Bde M, Melo WG, Melo FL, Lopes EP, Domingues AL, et al. Correlation of biological serum markers with the degree of hepatic fibrosis and necroinflammatory activity in hepatitis C and schistosomiasis patients. Mem Inst Oswaldo Cruz. 2010;105:460\u20136.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5791_CR46","doi-asserted-by":"publisher","first-page":"6843","DOI":"10.1007\/s11033-012-1509-z","volume":"39","author":"NE El-Bassiouni","year":"2012","unstructured":"El-Bassiouni NE, Nosseir MM, Madkour ME, Zoheiry MM, Bekheit IW, Ibrahim RA, et al. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma. Mol Biol Rep. 2012;39:6843\u201350.","journal-title":"Mol Biol Rep"},{"key":"5791_CR47","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3748\/wjg.v19.i8.1230","volume":"19","author":"P Liu","year":"2013","unstructured":"Liu P, Wang M, Lu XD, Zhang SJ, Tang WX. Schistosoma japonicum egg antigen up-regulates fibrogenesis and inhibits proliferation in primary hepatic stellate cells in a concentration-dependent manner. World J Gastroenterol. 2013;19:1230\u20138.","journal-title":"World J Gastroenterol"},{"key":"5791_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136453","volume":"10","author":"YH Huang","year":"2015","unstructured":"Huang YH, Tiao MM, Huang LT, Chuang JH, Kuo KC, Yang YL, et al. Activation of Mir-29a in activated hepatic stellate cells modulates its profibrogenic phenotype through inhibition of histone deacetylases 4. PLoS ONE. 2015;10:e0136453.","journal-title":"PLoS ONE"},{"key":"5791_CR49","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/cells8101298","volume":"8","author":"HY Lin","year":"2019","unstructured":"Lin HY, Wang FS, Yang YL, Huang YH. MicroRNA-29a suppresses CD36 to ameliorate high fat diet-induced steatohepatitis and liver fibrosis in mice. Cells. 2019;8:1298.","journal-title":"Cells"},{"key":"5791_CR50","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/mt.2016.127","volume":"24","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto Y, Itami S, Kuroda M, Yoshizato K, Kawada N, Murakami Y. MiR-29a assists in preventing the activation of human stellate cells and promotes recovery from liver fibrosis in mice. Mol Ther. 2016;24:1848\u201359.","journal-title":"Mol Ther"},{"key":"5791_CR51","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1111\/j.1440-1746.2006.04658.x","volume":"22","author":"T Kisseleva","year":"2007","unstructured":"Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol. 2007;22:S73\u20138.","journal-title":"J Gastroenterol Hepatol"},{"key":"5791_CR52","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.4049\/jimmunol.181.10.7214","volume":"181","author":"DR Herbert","year":"2008","unstructured":"Herbert DR, Orekov T, Perkins C, Finkelman FD. IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol. 2008;181:7214\u201320.","journal-title":"J Immunol"},{"key":"5791_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s13071-016-1799-4","volume":"9","author":"BM Tebeje","year":"2016","unstructured":"Tebeje BM, Harvie M, You H, Loukas A, McManus DP. Schistosomiasis vaccines: where do we stand? Parasit Vectors. 2016;9:528.","journal-title":"Parasit Vectors"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05791-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05791-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:54:35Z","timestamp":1686099275000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05791-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5791"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05791-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"26 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The human study was approved by the Ethics Committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (permit number: 20150103). Studies were performed according to the Declaration of Helsinki and with written informed consent from every patient. All animal experiments were performed in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and were approved by the Institutional Animal Care and Use Committee (IACUC) of Tongji Medical College, Huazhong University of Science and Technology (IACUC no. 629).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"184"}}